Patents for A61P 35 - Antineoplastic agents (221,099)
12/1988
12/07/1988EP0293708A1 Stable formulations of 5-fluorouracil
12/06/1988US4789665 Anticarcinogenic agents; daunorubicin derivatives
12/06/1988US4789658 Immunoprophylactic and immunotherapeutic agents
12/06/1988US4789587 (1,3-dioxolan-2-yl-methyl)-1H-imidazoles as bactericidal and/or fungicidal agents
12/06/1988US4789501 Yttria, silica, and alumina; radiation therapy of cancer
12/06/1988CA1246087A1 Cyclic-disulfonic ester compounds
12/06/1988CA1246062A1 Anthracyclin derivatives, a process for their preparation and their use as cytostatic agents
12/06/1988CA1246057A1 (amido)-n-substituted bleomycins, salts thereof and process for preparation thereof
12/01/1988WO1988009387A1 A method for detecting the predisposition to retinoblastoma and a method for detecting a retinoblastoma gene defect in tumors using a retinoblastoma gene probe
12/01/1988WO1988009384A1 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method
12/01/1988WO1988009347A1 Novel heparin derivatives
12/01/1988WO1988009168A1 Liposome/doxorubicin composition and method
12/01/1988WO1988009166A1 Liposome compositions of anthracycline derivatives
12/01/1988WO1988009123A1 Method of selectively inhibiting hiv
11/1988
11/30/1988EP0293266A2 A method for detecting the predisposition to retinoblastoma and a method for detecting a retinoblastoma gene in tumors using a retinoblastoma gene probe
11/30/1988EP0293155A2 Cancer-related antigen-specific human immunoglobulins and human/human hybridomas having the ability to produce said human immunoglobulins
11/30/1988EP0293078A1 Pharmaceutically active amines
11/29/1988US4788219 Antimetastatic agent
11/29/1988US4788213 Benzopyranyl and benzothiopyranyl compounds and uses
11/29/1988CA1245642A1 Aminonaphthacene derivatives and their production
11/29/1988CA1245640A1 8.alpha.-ACYLAMINOERGOLINES
11/23/1988EP0292348A1 Polycyclic heterocyclic derivatives, proces for their preparation and their use in human and veterinary medicines
11/23/1988EP0292334A2 GRF Analogs
11/23/1988EP0292291A2 Linear and cyclic analogs of alpha-msh fragments with extraordinary potency
11/23/1988EP0291957A2 Nitrogen containing derivatives of epipodophyllotoxin glucosides, a process for preparing them and pharmaceutical compositions
11/23/1988EP0291804A2 Proteins with a TNF effect
11/23/1988EP0291686A2 Inhibitors of angiogenin
11/23/1988EP0291636A1 Immune response to viruses induced by anti-idiotype antibodies
11/22/1988US4786723 7-hydroxyguanine compounds, process for preparing said compounds, and anti-tumor agent containing the same
11/22/1988US4786496 Chlorella
11/22/1988CA1245153A1 Cell matrix receptor system and use in cancer diagnosis and management
11/17/1988WO1988008715A1 Method of tumor inhibition in warm-blooded animals
11/17/1988EP0291270A2 Improvements in or relating to ergoline derivatives
11/17/1988EP0291269A2 Anti-tumour sulfonyl urea derivatives
11/17/1988EP0290948A2 Oncostatin M and novel compositions having anti-neoplastic activity
11/17/1988EP0290817A2 A Use of oxetanocin for inhibiting HIV
11/17/1988EP0290744A2 Anthracycline compounds and use thereof
11/17/1988EP0290442A1 Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts
11/17/1988EP0166726B1 10-ethyl-8,10-dideazaminopterins
11/15/1988US4785085 Rebeccamycin analogs
11/15/1988US4785077 Proteinaceous lymphokine as antitumor agents
11/15/1988US4784116 Capsule for interstitial implants
11/15/1988CA1244824A1 Aminopropylaminobleomycin derivatives and process for preparation thereof
11/15/1988CA1244765A1 Pyridine soluble extrait refined detoxified endotoxin composition and use
11/09/1988EP0290296A2 Liposomal formulations with a high antineoplastic agent/lipid ratio
11/09/1988EP0290169A2 Diamineplatinum complexes with phosphonocarboxylate and substituted phosphonocarboxylate ligands as antitumor agents
11/09/1988EP0290130A1 Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid like activity
11/09/1988EP0289949A2 Intercellular adhesion molecules, and their binding ligands
11/09/1988EP0289667A1 SOD active agent and method of manufacture thereof
11/09/1988CN88101810A Immunoglobulin conjugates
11/09/1988CN87104045A Trichothecent conjugates
11/08/1988US4783533 [Oxo-4-4H-[1]-benzopyran-8-yl]alcanoic acids, salts and derivatives, their manufacture and medicines containing them
11/08/1988US4783478 Treatment of emesis, nausea and vomiting
11/08/1988US4783452 Antitumor agents
11/08/1988CA1244471A1 Composition active against mites, whitefly and thrips, and new benzoylurea compounds
11/08/1988CA1244455A1 Tricyclophosphazene derivatives, their preparation and their use in pharmaceuticals
11/08/1988CA1244430A1 Bis-dioxopiperazine derivatives, process for their preparation, antitumor agents comprising them and compositions containing them
11/08/1988CA1244412A1 Mitomycin analogs
11/08/1988CA1244364A1 Anthracycline derivatives, a microbiological process for their preparation and their use as cytostatics
11/08/1988CA1244344A1 Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor- associated markers
11/03/1988WO1988008444A1 Process for preparing oil composition
11/03/1988WO1988008424A1 Pharmaceutically active amines
11/02/1988EP0289371A1 Imidazopyridine derivatives, their preparation and therapeutical use
11/02/1988EP0289204A2 Lithium salt-containing pharmaceutical compositions
11/02/1988EP0289203A1 Antitumor and antiviral compounds of marine origin
11/02/1988EP0288888A2 Novel glucopyranose derivatives
11/02/1988EP0288809A1 Bifunctional proteins
11/01/1988US4782113 Anticancer
11/01/1988US4782063 Ergoline esters useful as serotonin antagonists
11/01/1988US4781676 Antitumor
11/01/1988CA1244050A1 N-phenylbenzamide derivatives, process for the preparation thereof and their application for controlling diseases of the immune system
11/01/1988CA1244022A1 Aminoalkyl substituted urea derivatives and method of treatment
11/01/1988CA1243955A1 Potentiator conferring resistance to infection
10/1988
10/26/1988EP0288395A2 Nitrosourea derivatives, process for their preparation and their therapeutical uses
10/26/1988EP0288268A2 4-Demethoxy-4-amino-anthracyclines
10/26/1988EP0288163A2 Oligodeoxynucleotides as inhibitors of the replication of retroviruses and the expression of oncogenes
10/26/1988EP0288055A1 Use of ODC inhibitors, dacarbazine, and interferon, in the treatment of malignant melanoma
10/26/1988EP0288002A2 Organo-platinum complex and use thereof
10/26/1988EP0287855A2 7-n,8-n-ethylenemitomycin 8-imines, pharmaceutical compositions and use
10/26/1988EP0287690A1 Stable solvent adducts of Z-1-(p-beta-dimethylamino-ethoxyphenyl)-1-(p-hydroxyphenyl)-2-phenylbut-1-ene
10/25/1988US4780313 Antitumor agents
10/25/1988CA1243603A1 Phosphonic acid complexes for the treatment of calcific tumors
10/20/1988WO1988007868A1 Cytolytic factor
10/20/1988WO1988007864A1 Adjuvant for certain antimitotic chemicals, obtained from vibrio cholerae
10/20/1988WO1988007863A1 Human somatomedin carrier protein subunits and process for producing them
10/19/1988EP0287317A2 Platinum complexes with one radiosensitizing ligand
10/19/1988EP0287128A1 Antitumor agent
10/19/1988EP0286926A2 Semi-synthetic rhodomycins, method for their preparation and their use as cytostatics
10/18/1988US4778912 Phospholipid derivatives
10/18/1988US4778797 Organo-silicon compounds, process for the manufacture of same, and anti-tumor agent comprising the compound
10/18/1988US4778785 Pharmaceutical composition for retarding and reducing cachexia
10/18/1988CA1243305A1 Muramyl peptides and processes for their manufacture
10/12/1988EP0285906A2 Active agent for combating tumours
10/11/1988US4777270 Macrocyclic polyether carboxylic acids
10/11/1988US4777241 Isolated from tumor cell cultures
10/11/1988CA1243025A1 Homocyclic derivatives
10/06/1988WO1988007553A1 Process for preparing antibody complex
10/06/1988WO1988007548A1 Leukaemia-inhibitory factor
10/06/1988WO1988007544A1 Inhibitors for replication of retroviruses and for the expression of oncogene products
10/06/1988WO1988007542A1 Poly(deoxyribonucleotides), pharmaceutical compositions, use and preparation of the poly(deoxyribonucleotides)